Next Article in Journal
Impact of Dietary Regime and Seasonality on Hindgut’s Mycobiota Diversity in Dairy Cows
Previous Article in Journal
Revolutionizing Malaria Vector Control: The Importance of Accurate Species Identification through Enhanced Molecular Capacity
Previous Article in Special Issue
The Halotolerant Probiotic Bacterium Enterococcus lactis ASF-2 from Al-Asfar Lake, Saudi Arabia, Reduces Inflammation in Carrageenan-Induced Paw Edema
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Clostridioides difficile Spores, MRSA, and Pseudomonas aeruginosa

by
Mohsen Hosseini
1,
Jinge Huang
2,
Myra D. Williams
3,
Gerardo Alexander Gonzalez
1,
Xiuping Jiang
2,
Joseph O. Falkinham III
3 and
William A. Ducker
1,*
1
Department of Chemical Engineering, Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg, VA 24061, USA
2
Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA
3
Department of Biological Sciences, Virginia Tech, Blacksburg, VA 24061, USA
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(1), 83; https://doi.org/10.3390/microorganisms12010083
Submission received: 22 November 2023 / Revised: 21 December 2023 / Accepted: 27 December 2023 / Published: 31 December 2023
(This article belongs to the Special Issue Antimicrobial Activities of Natural Products)

Abstract

:
Antimicrobial coatings can inhibit the transmission of infectious diseases when they provide a quick kill that is achieved long after the coating application. Here, we describe the fabrication and testing of a glass coating containing Ag2O microparticles that was prepared from sodium silicate at room temperature. The half-lives of both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa on this coating are only 2–4 min. The half-life of Clostridioides difficile spores is about 9–12 min, which is extremely short for a spore. Additional tests on MRSA demonstrate that the coating retains its antimicrobial activity after abrasion and that an increased loading of Ag2O leads to a shorter half-life. This coating combines the properties of optical transparency, robustness, fast kill, and room temperature preparation that are highly desirable for an antimicrobial coating.

1. Introduction

Bacteria play a significant role in causing many healthcare-related diseases and deaths. They are transferred between people via a variety of mechanisms (skin-to-skin contact, droplet-borne, airborne, vector-borne, etc.) [1], but our particular interest here is in bacteria that are transmitted via inanimate surfaces. Bacteria remain viable on solids for an extended period (hours to months) [2]. Human contact with handrails, doorknobs, touchscreens, buttons, etc., is a route to transmission [3,4,5,6], and such contacts occur frequently in hospitals. Our overarching goal is to reduce the number of healthcare-related infections through the use of antimicrobial coatings that could be applied to common touch surfaces, such as hand-railings, or high-touch surfaces in healthcare settings, etc.
Current methods for reducing surface transmission encompass practices such as hand washing, cleaning, and surface disinfection [7]. However, these methods demand fastidious attention and repetition on a timescale that is shorter than the time between users. The use of chemical disinfectants also comes with its own set of health-related risks, such as potential harm to the eyes, skin, and respiratory tract [8]. Additionally, some disinfectants, such as bleach, are environmentally harmful, so continual application is not ideal.
Coatings are used in various applications [9,10,11,12], and an alternative or complementary approach for mitigating infection via surfaces is the development and implementation of antimicrobial coatings. These coatings operate on two timescales. They must provide (1) a fast kill: a kill time faster than the period between users, and (2) an ongoing kill: the fast kill should be effective over weeks, months, or even years in order to save the cost and inconvenience of reapplying the coating.
Antibacterial coatings have been reviewed [7,13,14,15,16], and metal oxide-based coatings containing silver (Ag), zinc (Zn), or copper (Cu) are proven to kill bacteria and viruses such as MRSA [17], E. coli [18], influenza A [19], SARS-CoV-2 [20,21], and norovirus [22]. The speed at which antimicrobial coatings kill bacteria is of paramount importance.
In this study, we use silver oxide (Ag2O) as the active ingredient of a coating. Ag2O has been widely used in the medical industry due to its robust mechanical properties and biocompatibility [23,24,25,26,27] and for antimicrobial materials [17,28,29,30,31,32,33,34]. For example, Tsendzughul et al. [24] fabricated an optically transparent film by sputtering silver oxide on a surface. A significant concern regarding the use of silver oxide is whether it exhibits any cytotoxic effects. Silver oxide has shown no sign of cytotoxicity against L929 fibroblast cells [29] and G292 osteoblastic cells [25]. A study onusing silver and silver oxide as an antimicrobial coating on footwear demonstrated impressive antibacterial properties without cytotoxicity [26]. Silver oxide is also used in urinary catheters to enhance infection resistance and has shown antimicrobial efficacy while remaining non-cytotoxic [27].
Our objective was to design and test a transparent and robust silver oxide antimicrobial coating that is fabricated at room temperature. A transparent coating is a necessity for important applications such as touchscreens and is desirable in many applications because of their aesthetics.
Test organisms for antimicrobial coatings should be those that are both medically significant pathogens and have significant transmission via surfaces. We test our coatings against Pseudomonas aeruginosa (P. aeruginosa), methicillin-resistant Staphylococcus aureus (MRSA), and Clostridioides difficile (C. difficile). P. aeruginosa (Gram-negative) is a significant cause of community and hospital-acquired infections and can be transferred through contaminated objects (fomites) [35]. P. aeruginosa spreads to organs that have already been damaged and those with implants [36]. P. aeruginosa causes between 10% and 20% of infections in most hospitals [37]. MRSA (Gram-positive) is an antibiotic-resistant strain of Staphylococcus aureus that causes pneumonia, sepsis, and skin infections. MRSA is typically found on the skin or nose. It can remain viable on surfaces for as long as months [2,38] and can be transmitted through direct contact or contaminated surfaces [39]. C. difficile is an anaerobic, Gram-positive spore-forming bacillus that is primarily found in the intestinal tract of humans and animals [40,41] and can cause diarrhea, colitis, and septicemia, potentially resulting in death [42]; in the US, 500,000 people annually are affected by this bacterium [43]. C. difficile is known to persist and spread through inanimate surfaces [44], surviving for up to 5 months on surfaces [44]; therefore, it is a good target for antimicrobial coatings.
Here, we describe a novel, transparent, and highly robust antimicrobial coating. The coating is primarily silicate glass, which is a robust and transparent material. Our design was to use 2 µm particles as a compromise between small particles to achieve a high surface-to-volume ratio while avoiding nanoparticles because of potential toxicological effects due to easier cellular entry [45]. We wanted the silver particles to span the coating, so the coating was less than 2 µm thick by design. Thicker coatings would submerge some particles, and thinner coatings would be less robust. The matrix was prepared by room-temperature spin coating of a sodium silicate solution containing a suspension of Ag2O particles. Very good antimicrobial properties were achieved: >3 logs (99.9%) of kills within 40 min for MRSA and P. aeruginosa, and 1.84 logs (98.6%) of kills within 60 min against C. difficile endospores.
In a previous work [17], we fabricated an optically transparent film by employing a variant of the Stöber process to bind silver oxide to surfaces, followed by a heat treatment at 50 °C for 40 min. Fabrication at 50 °C is a practical disadvantage for coatings applied to existing infrastructure; typical infrastructure, such as a touch screen or railing, cannot be maintained at 50 °C in the field. Here, we describe a novel coating method that can be applied at room temperature, overcoming this limitation. The new coating method also has the following advantages over the previous method: it eliminates a 40-h reaction with ammonia, a category 3 toxin that causes acute hazards to the aquatic environment [46] and, therefore, is less suitable for field application. This is achieved by using a different coating method based on sodium silicate. By eliminating ammonia, we also eliminate a (Lewis base) ligand that binds strongly to metal cations [47]. As a result, in contrast to previous work, we are able to maintain the morphology of the Ag2O particles during the fabrication of the coating. This advantage will likely apply to other particles that react or dissolve in ammonia. Longevity and resistance to abrasion are important to increase the period between repeated applications of the coating. Here, we also show that the new coating is highly abrasion-resistant by demonstrating the antimicrobial properties after abrasion. Compared to our previous Ag2O coating [17], the new coating is more potent and kills almost 2 logs of MRSA in only 20 min, whereas the previous coating did not produce a measurable kill in this time. The new coating kills almost two logs of C. difficile endospores in 60 min. This is particularly notable because, despite its clinical importance, we find no reports of similar or better killing of C. difficile by any coating in the literature.

2. Materials and Methods

2.1. Materials

Silver nitrate (AgNO3) 99.9% and ammonia solution certified as ACS Plus were purchased from Fisher Scientific (Waltham, MA, USA). Sodium hydroxide pellets (NaOH, ACS grade), 100% Ethanol (EtOH, ACS grade), nitric acid (ACS grade), and glass slides measuring 25 × 75 × 1 mm were obtained from VWR (Radnor, PA, USA). Sodium silicate solution (catalog model N) was generously provided by PQ Corporation (Malvern, PA, USA). Deionized (DI) water was used from a Milli-Q Reference (MilliporeSigma, Burlington, MA, USA) water purification system. All water used in the preparation of the coatings was purified water from the Milli-Q Reference system.

2.2. Ag2O Microparticle Synthesis

The synthesis of silver oxide microparticles has been discussed previously [48]. Here, 200 mL of aqueous 0.1 M AgNO3 was stirred while 400 mL of aqueous 0.1 M ammonia was introduced dropwise, stirred for an additional 10 min, and then 20 mL of 2 M NaOH solution was slowly added. This introduction of NaOH caused the solution to transition into a deep brown color, signaling the formation of silver oxide precipitates. The resulting suspension was left undisturbed at room temperature overnight, during which time, silver oxide particles gradually sedimented. The supernatant was then decanted, and silver oxide particles were rinsed three times with DI water and then three times with ethanol. Finally, the collected particles were allowed to air dry.

2.3. Preparation of Silver Oxide Coatings

Glass slides were cut into 15 × 15 mm samples and subjected to a rinse with DI water, ethanol, 6 M nitric acid, and another 3× DI water. A uniform 75% vol. solution of sodium silicate in water was prepared by vortexing for 30 s and then leaving in an ultrasonic bath for 3 min. The viscosity was 1.08 mPs and pH was 11; Ag2O particles are resistant to this pH. This solution was used to create a 13.5% wt. silver oxide in sodium silicate suspension that was homogenized by vortexing for 30 s and ultrasonic waves for >10 min. Glass pieces underwent O2 plasma cleaning at 100 W with a pressure of less than 200 torr for 4 min and then were immediately positioned on a spin coater. A 100 µL suspension solution was applied to the surface of the substrate and spin-coated for 30 s at 1200 rpm and with a startup acceleration of 3000 rpm/s. The resulting samples are described as the “Ag2O coating” in the remainder of this paper.

2.4. Characterization of Microparticles and Coatings

The crystal structure of the synthesized Ag2O particles was determined by analyzing the X-ray diffraction (XRD, Bruker D8 Advance diffractometer with a monochromatic Cu Kα X-ray source with a wavelength of 1.5418 Å). The peaks in the range of 2θ = 20–80° were compared to the known structure of Ag2O to check consistency with the product being crystalline Ag2O. The chemical composition of the few outer nanometers of the surface of the Ag2O coating was obtained using a survey spectrum using X-ray photoelectron spectroscopy (XPS, PHI VersaProbe III (Chanhassen, MN, USA) with Al Kα source at 1486.6 eV). The coating morphology was examined using scanning electron microscopy (SEM, JEOL, Japan JSM-IT500). The sample was sputtered with 5 nm of iridium in a no-tilt position to increase the signal-to-noise ratio during the SEM imaging of the nonconductive materials. Optical transmittance measurements were performed using an Agilent model 8453 UV−Vis spectrometer. Air was used as the blank spectrum.

2.5. Microbial Strains

We utilized P. aeruginosa strain DSM-9644, C. difficile (ATCC 43593) endospores, and a strain of methicillin-resistant Staphylococcus aureus (MRSA) known as MA43300, which was sourced from Danville Community Hospital in Danville, Virginia.

2.6. Growth of Microbial Strains

P. aeruginosa and MRSA strains were cultured in 5 mL of Tryptic Soy Broth (TSB) and were grown to the mid-exponential phase at 37 °C with continuous aeration at 60 rpm. After the growth phase, we confirmed the purity and identity of the cells in the cultures by streaking the bacterial cultures onto Tryptic Soy Agar (TSA) from BD (Sparks, MD, USA) and incubating them at 37 °C for 48 h. During this period, we examined the colonies for species-specific characteristics, such as pigmentation and surface texture. Cultured cells were harvested through centrifugation at 5000× g for 20 min. Afterward, the supernatant medium was removed, and the cells were resuspended in 5 mL of sterile phosphate-buffered saline (PBS) by vortexing for 60 s. These suspensions were subjected to another round of centrifugation at 5000× g for 20 min, and the supernatant wash was discarded. Subsequently, the washed cells were resuspended in 5 mL of sterile PBS by vortexing for an additional 60 s. To determine the density of colony-forming units (CFU) per milliliter in each of the washed suspensions, we plated 0.10 mL of serial dilutions in PBS onto TSA plates.
C. difficile (ATCC 43593) was cultured on modified brain heart infusion agar plates containing 5 g/L yeast extract, 1 g/L cysteine, and 1 g/L sodium taurocholate (BHIA/YE/CYS/T), and incubated inside an anaerobic chamber (BactronEZ, Sheldon Manufacturing, OR, U.S.) at 37 °C for 7 days as previously described [49]. Then, all plates were sealed with Parafilm™ (Pechiney, IL, USA) and incubated under ambient conditions for another 7 days. Each agar plate was flooded with 5 mL of 0.01 M phosphate-buffered saline (PBS) with 0.1% (vol/vol) Tween-80, and the colony mass was scraped from the agar plates using sterile cotton swabs. The cell suspension was washed 5 times with ice-cold sterile deionized (DI) water, followed by centrifugation at 7000× g for 5 min at 4 °C. Vegetative cells of C. difficile were removed by gradient centrifugation in 50% (w/v) sucrose solution [50], then the endospore suspension was washed three times with sterile ice-cold water. The concentration of endospores was enumerated on BHIA/YE/CYS/T plates, and the purity of prepared endospores was confirmed under a microscope after endospore staining [51]. The stock culture of C. difficile endospores at 108 colony-forming units (CFU)/mL was stored at 4 °C for routine tests and at −80 °C for long-term storage.

2.7. Measurement of Cell Number and Surface Killing

2.7.1. P. aeruginosa and MRSA

The bacterial cell numbers in the PBS suspensions were measured from the CFU per milliliter of the suspension by spreading 0.1 mL of each solution onto TSA plates in triplicate. Survival on the Ag2O coating was determined by depositing a 10 μL droplet of bacterial cell suspension onto each of three separate Ag2O coated and uncoated samples at each time-point displayed in the Figures. After predefined time periods, each glass coupon was transferred to an individual sterile 50 mL centrifuge tube containing 5 mL of sterile PBS. Subsequently, the tubes were vortexed for 10 s and sonicated for one minute to release bacteria. A volume of 0.1 mL of the suspension was then spread-plated, which represents 1/50 of the surviving colonies; a series dilution was also plated. Colonies were counted 48 h after incubation at 37 °C. To enable the logarithmic transformation in Equation (1), cases where no colonies were observed for the 1/50 dilution were rounded up to one colony. One colony on the plate is the detection limit displayed in the figures.

2.7.2. C. difficile Endospores

Prior to testing the antimicrobial properties, samples were rinsed in 75% ethanol for 10 min and air-dried in 100-mm Petri dishes with lids on under a biosafety cabinet at room temperature (20–25 °C). Twenty microliters of C. difficile endospore suspension were inoculated onto the center of each sample and spread to within 3 mm of the edge of each carrier by sterile pipette tips. Triplicate inoculated samples were incubated aerobically at room temperature for up to 60 min. After the predefined incubation times, each sample was immediately transferred to a 50-mL conical tube with 20 mL Dey/Engley neutralization broth. All samples were sonicated at 40 kHz for 5 min and vortexed for 30 s, and the surviving C. difficile endospores from each sample were enumerated on anaerobic BHIA/YE/T/CYS plates.

2.8. Coating Robustness

The United States Environmental Protection Agency (EPA) has published a protocol [52] for assessing the effectiveness of antibacterial coatings. A sponge (Brite (3M, Saint Paul, MN, USA) Non-Scratch Scrub Sponge, model C05068) used for abrasion was autoclaved, then left to completely dry overnight in a laminar flow hood. Subsequently, the sponge was immersed in 20 mL of 1:6 Lysol in DI water solution for ten minutes, and then the partially wet sponge was affixed to a Gardco model D10 V abrasion tester. The abrasion tester translates the sponge parallel to the active surface of the sample under a load of 0.454 kg, with a period of 2.2 s and a displacement of 0.3 m. Each cycle consists of moving the sponge back and forth over the sample eight times, followed by a 30-min waiting period. Ten such cycles were conducted, totaling 80 passes. Owing to evaporation, the nature of the sponge changed, so cycles 6–10 used a fresh sponge that was also wetted with Lysol solution. Finally, the abraded samples were dipped in sterile deionized water for >10 min and then rinsed 3× with sterile deionized water to remove the remaining Lysol solution.

3. Results and Discussion

3.1. Coated Glass Is Transparent and Contains Exposed Silver Oxide

Glass slides were coated at room temperature with the antimicrobial layer of glass containing Ag2O. We synthesized silver oxide microparticles (Figure S1) and confirmed their cubic crystalline structure using XRD. The coated glass was uniformly 80% transparent, as shown by both the transmission spectrum and a photograph of a colored cell phone screen containing a coated glass screen protector (Figure 1). The silver oxide particles protruded beyond the main glass matrix (Figure 2) and, therefore, were suitably positioned for releasing silver ions. SEM images are not sensitive to a thin layer of glass over the particles, so XPS measurements were performed to determine whether the Ag2O was exposed. The presence of 6.9 atomic % silver in the XPS spectrum indicated that Ag2O was at or within a few nanometers of the coating surface (Figure 3).

3.2. The Ag2O Coating Has Strong Antimicrobial Activity

The Ag2O coating exhibited strong antimicrobial activity for MRSA, P. aeruginosa, and C. difficile endospores (Figure 4 and Table 1). The data was plotted as log survival, which is a comparison between the initial titer applied to the solid and the titer recovered from a sample at a designated time:
log   survival = mean [ log 10 ( sample   titer units ) ] mean [ log 10 ( input   titer units ) ]
The coating achieved >99.9% killing for both MRSA and P. aeruginosa in 40 min, and the half-lives were in the range of 2–4 min (see Table 1). These results meet the standard EPA guideline of 99.9% killing in 60 min and are in agreement with the results for earlier Ag2O coatings [17], but the current coatings are superior because they are more robust and are prepared at room temperature.
Our antimicrobial coatings were tested on spore-only suspensions of C. difficile. It is much more difficult to kill spores of C. difficile than MRSA or P. aeruginosa because spores are relatively impermeable, have protective multilayers, and reduced metabolism [53]. The coating showed an outstanding sporicidal response against C. difficile by killing 98.55% in one hour. The data for C. difficile, shown in Figure 4, exhibits a linear decline of log survival over the entire 60 min time frame, which is characteristic of killing a homogeneous population (cf. data for other organisms in Figure 4) and is consistent with the killing of spores, not the killing of easy-to-kill vegetative cells in a mixture of spores and vegetative cells.
The half-life for C. difficile on the coating was about 10 min, which is excellent for spores. Prior publications on both copper and copper-rich alloys (opaque solids) reported that hours were required to kill C. difficile [54] or that copper was ineffective [55]. When a germinant was added to the test droplet, the killing of 2.5 logs (99.8% kill) after 3 h was reported. The authors describe this as killing “germinating” cells [55]. In contrast, no germinant was added to the test suspension in the current work.
One can envisage a scenario where C. difficile spores in a hospital escape disinfection due to human error and then, even months later, infect another patient. The advantage of a coating is that it can continue to kill C. difficile over the long term without human intervention.

3.3. Antimicrobial Activity Depends on the Silver Loading

A control experiment showed that when no silver was added, there was no antimicrobial activity (Figure S2), which is consistent with Ag2O being the active ingredient. To determine the dose–response of Ag2O in the coating, a series of coatings with equal or lower density than elsewhere in this manuscript was also tested. The three loadings were 0.36 gm−2 (33%), 0.73 gm−2 (66%), and 1.10 gm−2 (100%). The log survival data shows that the rate of killing depended on the loading, which is strong additional support that Ag2O is the active ingredient. The results also indicate that the loading is not saturated in this regime, so it is likely that faster killing could be achieved for greater loading. Our hypothesis was that additional Ag2O should decrease the half-life. We tested this by fitting all the data used to obtain Figure 5 with a model where log Survival depends on time (min), t , the loading (gm−2), l , and an interaction term, t L , with constant coefficients, A , B , C , and D :
log   Survival = A B t C l D t l .
The only significant coefficient was for the t l interaction term (p = 2 × 10−8), demonstrating that increasing the loading decreased the half-life. The fitted half-life in minutes is t 1 / 2 = 5.3 / l , where l is the loading in units of gm−2.

3.4. Antimicrobial Activity Is Retained after Abrasion

In practice, antimicrobial coatings are used in environments where they are subject to abrasion. To account for this, the US EPA has published a protocol for testing antimicrobial coatings where they are subject to abrasion [52]. We used the same abrasion cycle and exposure to Lysol disinfectant in a modified version of their protocol and then tested its ability to kill MRSA. The results (Figure 6) show a resistance to abrasion: a 4-log-reduction in 60 min was achieved after abrasion, which is similar to the results prior to abrasion (Figure 4 and Figure 5). The ability of the coating to kill bacteria after light abrasion is not surprising, considering that the coating is mainly composed of glass. We designed a thin coating so that all the particles would protrude. Future work could use a thicker coating such that initially submerged particles could be exposed after abrasion removes the outer layer of glass and, from that time, provide fresh antimicrobial activity for the worn coating.

4. Conclusions

Our objective was to fabricate a transparent antimicrobial coating at room temperature, which we achieved by spin-coating a suspension of Ag2O microparticles in a sodium silicate solution. The coating was highly effective; it killed >99.9% of P. aeruginosa, >99.9% MRSA cells in 40 min, and 98.55% of C. difficile spores in 60 min. The results for C. difficile spores are particularly notable because they are more difficult to kill. Being primarily glass, the coating is also robust to abrasion and transparent. The combination of transparency, room temperature fabrication, and excellent antimicrobial properties may be useful for combatting the transmission of infectious diseases.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms12010083/s1, Figure S1: Equations used for calculations, further characterization of materials, and data for control coatings. XRD pattern and SEM image of the silver oxide particles. Figure S2: Survival of MRSA cells on a silicate coating with no Ag2O. Figure S3: Effect of Ag2O loading on antimicrobial activity.

Author Contributions

Conceptualization, W.A.D. and M.H.; methodology, M.H., X.J., J.O.F.III and W.A.D.; validation, M.H., M.D.W. and J.H.; formal analysis, M.H.; investigation, M.H., M.D.W., J.H. and G.A.G.; resources, W.A.D., J.O.F.III and X.J.; data curation, M.H.; writing—original draft preparation, M.H., W.A.D., G.A.G. and J.H.; writing—review and editing, W.A.D., J.O.F.III, X.J. and M.H.; visualization, M.H.; supervision, W.A.D., J.O.F.III and X.J.; project administration, W.A.D.; funding acquisition, W.A.D., J.O.F.III, X.J. and M.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a Virginia Tech Proof of Concept grant, and the National Science Foundation, grant numbers CHE-1531834. The work carried out by M.H. is partially funded by David W. and Lillian Francis Memorial Fellowship provided by Virginia Tech.

Data Availability Statement

Data will be provided on request.

Acknowledgments

This work was supported by the National Science Foundation grant number CBET-1902364 and a Virginia Tech Proof of Concept grant. M.H. was funded through the David W. and Lillian Francis Memorial Fellowship. The authors thank the Surface Analysis Laboratory in the Department of Chemistry at Virginia Tech for capturing the XPS spectrum, which is supported by the National Science Foundation under Grant No. CHE-1531834 and used shared facilities at the Nanoscale Characterization and Fabrication Laboratory, which is funded and managed by Virginia Tech’s Institute for Critical Technology and Applied Science. Additional support is provided by the Virginia Tech National Center for Earth and Environmental Nanotechnology Infrastructure (NanoEarth), a member of the National Nanotechnology Coordinated Infrastructure (NNCI), supported by the NSF (ECCS 1542100 and ECCS 2025151). The PQ Corporation provided the sodium silicate.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Antonovics, J.; Wilson, A.J.; Forbes, M.R.; Hauffe, H.C.; Kallio, E.R.; Leggett, H.C.; Longdon, B.; Okamura, B.; Sait, S.M.; Webster, J.P. The Evolution of Transmission Mode. Philos. Trans. R. Soc. B Biol. Sci. 2017, 372, 20160083. [Google Scholar] [CrossRef] [PubMed]
  2. Kramer, A.; Schwebke, I.; Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6, 130. [Google Scholar] [CrossRef] [PubMed]
  3. CDC. Pseudomonas aeruginosa in Healthcare Settings. Available online: https://www.cdc.gov/hai/organisms/pseudomonas.html (accessed on 25 October 2023).
  4. CDC. Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings. Available online: https://www.cdc.gov/hai/organisms/vre/vre.html (accessed on 25 October 2023).
  5. CDC. Available online: https://www.cdc.gov/mrsa/healthcare/index.html (accessed on 25 October 2023).
  6. Duizer, E.; Koopmans, M. Tracking foodborne viruses: Lessons from noroviruses. In Emerging Food-Borne Pathogens; Motarjemi, Y., Adams, M., Eds.; CRC Press: Boca Raton, FL, USA, 2006; pp. 77–110. [Google Scholar]
  7. Birkett, M.; Dover, L.; Cherian Lukose, C.; Wasy Zia, A.; Tambuwala, M.M.; Serrano-Aroca, Á. Recent advances in metal-based antimicrobial coatings for high-touch surfaces. Int. J. Mol. Sci. 2022, 23, 1162. [Google Scholar] [CrossRef] [PubMed]
  8. Ghosh, S.; Mukherjee, R.; Mahajan, V.S.; Boucau, J.; Pillai, S.; Haldar, J. Permanent, antimicrobial coating to rapidly kill and prevent transmission of bacteria, fungi, influenza, and SARS-CoV-2. ACS Appl. Mater. Interfaces 2022, 14, 42483–42493. [Google Scholar] [CrossRef] [PubMed]
  9. Driver, M. Coatings for Biomedical Applications; Elsevier: Amsterdam, The Netherlands, 2012. [Google Scholar]
  10. Schweitzer, P.A. Paint and Coatings: Applications and Corrosion Resistance; CRC Press: Boca Raton, FL, USA, 2005. [Google Scholar]
  11. Olding, T.; Sayer, M.; Barrow, D. Ceramic sol–gel composite coatings for electrical insulation. Thin Solid Film. 2001, 398, 581–586. [Google Scholar] [CrossRef]
  12. Hosseini, M.; Rodriguez, A.; Ducker, W.A. Super-enhanced evaporation of droplets from porous coatings. J. Colloid Interface Sci. 2023, 633, 132–141. [Google Scholar] [CrossRef]
  13. Knetsch, M.L.; Koole, L.H. New strategies in the development of antimicrobial coatings: The example of increasing usage of silver and silver nanoparticles. Polymers 2011, 3, 340–366. [Google Scholar] [CrossRef]
  14. Vigneswari, S.; Amelia, T.S.M.; Hazwan, M.H.; Mouriya, G.K.; Bhubalan, K.; Amirul, A.-A.A.; Ramakrishna, S. Transformation of biowaste for medical applications: Incorporation of biologically derived silver nanoparticles as antimicrobial coating. Antibiotics 2021, 10, 229. [Google Scholar] [CrossRef]
  15. Hosseini, M.; Poon, L.L.; Chin, A.W.; Ducker, W.A. Effect of surface porosity on SARS-CoV-2 fomite infectivity. ACS Omega 2022, 7, 18238–18246. [Google Scholar] [CrossRef]
  16. Hosseini, M.; Behzadinasab, S.; Benmamoun, Z.; Ducker, W.A. The Viability of SARS-COV-2 on Solid Surfaces. Curr. Opin. Colloid Interface Sci. 2021, 55, 101481. [Google Scholar] [CrossRef]
  17. Hosseini, M.; Chin, A.W.; Williams, M.D.; Behzadinasab, S.; Falkinham, J.O., III; Poon, L.L.; Ducker, W.A. Transparent anti-SARS-CoV-2 and antibacterial silver oxide coatings. ACS Appl. Mater. Interfaces 2022, 14, 8718–8727. [Google Scholar] [CrossRef] [PubMed]
  18. Jin, T.; Sun, D.; Su, J.; Zhang, H.-W.; Sue, H.J. Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis, and Escherichia coli O157:H7. J. Food Sci. 2009, 74, M46–M52. [Google Scholar] [CrossRef] [PubMed]
  19. Perelshtein, I.; Levi, I.; Perkas, N.; Pollak, A.; Gedanken, A. CuO-coated antibacterial and antiviral car air-conditioning filters. ACS Appl. Mater. Interfaces 2022, 14, 24850–24855. [Google Scholar] [CrossRef] [PubMed]
  20. Hosseini, M.; Behzadinasab, S.; Chin, A.W.; Poon, L.L.; Ducker, W.A. Reduction of Infectivity of SARS-CoV-2 by Zinc Oxide Coatings. ACS Biomater. Sci. Eng. 2021, 7, 5022–5027. [Google Scholar] [CrossRef] [PubMed]
  21. Hosseini, M.; Chin, A.W.; Behzadinasab, S.; Poon, L.L.; Ducker, W.A. Cupric Oxide Coating That Rapidly Reduces Infection by SARS-CoV-2 via Solids. ACS Appl. Mater. Interfaces 2021, 13, 5919–5928. [Google Scholar] [CrossRef] [PubMed]
  22. Michels, H.T.; Keevil, C.W.; Salgado, C.D.; Schmidt, M.G. From laboratory research to a clinical trial: Copper alloy surfaces kill bacteria and reduce hospital-acquired infections. HERD Health Environ. Res. Des. J. 2015, 9, 64–79. [Google Scholar] [CrossRef] [PubMed]
  23. Devi, P.S.; Vijayalakshmi, K. Analysis of antibacterial activity and cytotoxicity of silver oxide doped hydroxyapatite exposed to DC glow discharge plasma. Mater. Today Proc. 2020, 26, 3604–3608. [Google Scholar] [CrossRef]
  24. Tsendzughul, N.T.; Ogwu, A.A. Physicochemical aspects of the mechanisms of rapid antimicrobial contact-killing by sputtered silver oxide thin films under visible light. ACS Omega 2019, 4, 16847–16859. [Google Scholar] [CrossRef]
  25. Shahrbabak, M.S.N.; Sharifianjazi, F.; Rahban, D.; Salimi, A. A Comparative Investigation on Bioactivity and Antibacterial Properties of Sol-Gel Derived 58S Bioactive Glass Substituted by Ag and Zn. Silicon 2019, 11, 2741–2751. [Google Scholar] [CrossRef]
  26. Carvalho, I.; Lima, M.J.; Nobre, D.; Marques, S.M.; Castro, D.; Leite, T.R.; Henriques, M.; Duarte, F.; Ramalho, A.; Carvalho, S. Silver oxide coatings deposited on leathers to prevent diabetic foot infections. Surf. Coat. Technol. 2022, 442, 128338. [Google Scholar] [CrossRef]
  27. Nandkumar, A.M.; Ranjit, M.; Kumar, S.P.; Hari, P.; Ramesh, P.; Sreenivasan, K. Antimicrobial silver oxide incorporated urinary catheters for infection resistance. Trends Biomater. Artif. Organs 2010, 24, 156–164. [Google Scholar]
  28. Yoo, J.-Y.; Jang, E.-Y.; Jeong, S.-Y.; Hwang, D.-Y.; Son, H.-J. Bacterial indoleacetic acid-induced synthesis of colloidal Ag2O nanocrystals and their biological activities. Bioprocess Biosyst. Eng. 2019, 42, 401–414. [Google Scholar] [CrossRef]
  29. Babu, P.J.; Doble, M.; Raichur, A.M. Silver Oxide Nanoparticles Embedded Silk Fibroin Spuns: Microwave Mediated Preparation, Characterization and Their Synergistic Wound Healing and Anti-bacterial Activity. J. Colloid Interface Sci. 2018, 513, 62–71. [Google Scholar] [CrossRef]
  30. Patel, H.; Joshi, J. Green and chemical approach for synthesis of Ag2O nanoparticles and their antimicrobial activity. J. Sol-Gel Sci. Technol. 2023, 105, 814–826. [Google Scholar] [CrossRef]
  31. Singh, G.; Singh, G.; Damarla, K.; Sharma, P.K.; Kumar, A.; Kang, T.S. Gelatin-based highly stretchable, self-healing, conducting, multiadhesive, and antimicrobial ionogels embedded with Ag2O nanoparticles. ACS Sustain. Chem. Eng. 2017, 5, 6568–6577. [Google Scholar] [CrossRef]
  32. Mani, M.; Harikrishnan, R.; Purushothaman, P.; Pavithra, S.; Rajkumar, P.; Kumaresan, S.; Al Farraj, D.A.; Elshikh, M.S.; Balasubramanian, B.; Kaviyarasu, K. Systematic green synthesis of silver oxide nanoparticles for antimicrobial activity. Environ. Res. 2021, 202, 111627. [Google Scholar] [CrossRef]
  33. Haq, S.; Rehman, W.; Waseem, M.; Meynen, V.; Awan, S.U.; Saeed, S.; Iqbal, N. Fabrication of pure and moxifloxacin functionalized silver oxide nanoparticles for photocatalytic and antimicrobial activity. J. Photochem. Photobiol. B Biol. 2018, 186, 116–124. [Google Scholar] [CrossRef]
  34. Li, R.; Chen, Z.; Ren, N.; Wang, Y.; Wang, Y.; Yu, F. Biosynthesis of silver oxide nanoparticles and their photocatalytic and antimicrobial activity evaluation for wound healing applications in nursing care. J. Photochem. Photobiol. B Biol. 2019, 199, 111593. [Google Scholar] [CrossRef]
  35. Page, K.; Wilson, M.; Parkin, I.P. Antimicrobial Surfaces and Their Potential in Reducing the Role of the Inanimate Environment in the Incidence of Hospital-acquired Infections. J. Mater. Chem. 2009, 19, 3819–3831. [Google Scholar] [CrossRef]
  36. Hardalo, C.; Edberg, S.C. Pseudomonas aeruginosa: Assessment of risk from drinking water. Crit. Rev. Microbiol. 1997, 23, 47–75. [Google Scholar] [CrossRef]
  37. Bodey, G.P.; Bolivar, R.; Fainstein, V.; Jadeja, L. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 1983, 5, 279–313. [Google Scholar] [CrossRef]
  38. Williams, C.; Davis, D.L. Methicillin-resistant Staphylococcus aureus fomite survival. Am. Soc. Clin. Lab. Sci. 2009, 22, 34–38. [Google Scholar]
  39. Zeller, J.L.; Burke, A.E.; Glass, R.M. MRSA infections. JAMA 2007, 298, 1826. [Google Scholar] [CrossRef]
  40. Czepiel, J.; Dróżdż, M.; Pituch, H.; Kuijper, E.J.; Perucki, W.; Mielimonka, A.; Goldman, S.; Wultańska, D.; Garlicki, A.; Biesiada, G. Clostridium difficile infection. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 1211–1221. [Google Scholar] [CrossRef]
  41. Smits, W.K.; Lyras, D.; Lacy, D.B.; Wilcox, M.H.; Kuijper, E.J. Clostridium difficile infection. Nat. Rev. Dis. Primers 2016, 2, 1–20. [Google Scholar] [CrossRef]
  42. Redelings, M.D.; Sorvillo, F.; Mascola, L. Increase in Clostridium difficile–related mortality rates, United States, 1999–2004. Emerg. Infect. Dis. 2007, 13, 1417. [Google Scholar] [CrossRef]
  43. Feuerstadt, P.; Theriault, N.; Tillotson, G. The burden of CDI in the United States: A multifactorial challenge. BMC Infect. Dis. 2023, 23, 132. [Google Scholar] [CrossRef]
  44. Claro, T.; Daniels, S.; Humphreys, H. Detecting Clostridium difficile spores from inanimate surfaces of the hospital environment: Which method is best? J. Clin. Microbiol. 2014, 52, 3426–3428. [Google Scholar] [CrossRef]
  45. Stark, W.J. Nanoparticles in biological systems. Angew. Chem. Int. Ed. 2011, 50, 1242–1258. [Google Scholar] [CrossRef]
  46. World Health Organization. Ammonia; World Health Organization: Geneva, Switzerland, 1986. [Google Scholar]
  47. Fox, B.S.; Beyer, M.K.; Bondybey, V.E. Coordination chemistry of silver cations. J. Am. Chem. Soc. 2002, 124, 13613–13623. [Google Scholar] [CrossRef]
  48. Wang, X.; Wu, H.-F.; Kuang, Q.; Huang, R.-B.; Xie, Z.-X.; Zheng, L.-S. Shape-dependent Antibacterial Activities of Ag2O Polyhedral Particles. Langmuir 2010, 26, 2774–2778. [Google Scholar] [CrossRef]
  49. Huang, J.; Park, G.W.; Jones, R.M.; Fraser, A.M.; Vinjé, J.; Jiang, X. Efficacy of EPA-registered disinfectants against two human norovirus surrogates and Clostridioides difficile endospores. J. Appl. Microbiol. 2022, 132, 4289–4299. [Google Scholar] [CrossRef]
  50. Edwards, A.N.; McBride, S.M. Isolating and purifying Clostridium difficile spores. Methods Protoc. 2016, 1476, 117–128. [Google Scholar]
  51. Nerandzic, M.M.; Donskey, C.J. A quaternary ammonium disinfectant containing germinants reduces Clostridium difficile spores on surfaces by inducing susceptibility to environmental stressors. Open Forum Infect. Dis. 2016, 30, ofw196. [Google Scholar] [CrossRef]
  52. United States Environmental Protection Agency. Interim Method for Evaluating the Efficacy of Antimicrobial Surface Coatings, 10/2/2020 ed.; United States Environmental Protection Agency: Washington, DC, USA, 2020. [Google Scholar]
  53. Setlow, P. Spore resistance properties. In The Bacterial Spore: From Molecules to Systems; Weily: Hoboken, NJ, USA, 2016; pp. 201–215. [Google Scholar]
  54. Weaver, L.; Michels, H.; Keevil, C. Survival of Clostridium difficile on copper and steel: Futuristic options for hospital hygiene. J. Hosp. Infect. 2008, 68, 145–151. [Google Scholar] [CrossRef]
  55. Wheeldon, L.; Worthington, T.; Lambert, P.A.; Hilton, A.; Lowden, C.; Elliott, T.S. Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: The germination theory. J. Antimicrob. Chemother. 2008, 62, 522–525. [Google Scholar] [CrossRef]
Figure 1. (A) Visible light transmission spectrum for a glass slide with the Ag2O coating. The background is air in both spectra. (B) Photograph of cell phone with an Ag2O-coated screen protector on the lower half. Note that various colors from the cell phone screen are transmitted, as suggested by the spectrum in (A).
Figure 1. (A) Visible light transmission spectrum for a glass slide with the Ag2O coating. The background is air in both spectra. (B) Photograph of cell phone with an Ag2O-coated screen protector on the lower half. Note that various colors from the cell phone screen are transmitted, as suggested by the spectrum in (A).
Microorganisms 12 00083 g001
Figure 2. SEM images of Ag2O particles embedded in the glass coating at different magnifications.
Figure 2. SEM images of Ag2O particles embedded in the glass coating at different magnifications.
Microorganisms 12 00083 g002
Figure 3. XPS spectrum of the Ag2O coating demonstrating that the silver is within a few nanometers of the coating surface.
Figure 3. XPS spectrum of the Ag2O coating demonstrating that the silver is within a few nanometers of the coating surface.
Microorganisms 12 00083 g003
Figure 4. Antimicrobial activity of the Ag2O coating towards MRSA and P. aeruginosa cells and C. difficile endospores. Data is presented for uncoated glass and coated glass at the same exposure time. Survival is defined in Equation (1). Each point represents the average of three independent measurements, and the error bar is the standard deviation of the three points. For MRSA, the 20 min point and 60 min point are the average 5 data points. Two outliers were discarded from the MRSA data due to a large residual from the mean. For both MRSA and P. aeruginosa, survival dropped below the detection limit within one hour. There are more survivors for C. difficile endospores, but it is a much more difficult organism to kill.
Figure 4. Antimicrobial activity of the Ag2O coating towards MRSA and P. aeruginosa cells and C. difficile endospores. Data is presented for uncoated glass and coated glass at the same exposure time. Survival is defined in Equation (1). Each point represents the average of three independent measurements, and the error bar is the standard deviation of the three points. For MRSA, the 20 min point and 60 min point are the average 5 data points. Two outliers were discarded from the MRSA data due to a large residual from the mean. For both MRSA and P. aeruginosa, survival dropped below the detection limit within one hour. There are more survivors for C. difficile endospores, but it is a much more difficult organism to kill.
Microorganisms 12 00083 g004
Figure 5. The effect of Ag2O loading on antimicrobial activity. The data used for Ag2O coating is the same as in Figure 4. The “Ag2O Coating” label is for the coating used elsewhere in this manuscript, and Ag2O-33% and Ag2O-66% indicate coating loadings that have 33% and 66% of that loading, respectively. Data as a function of loading is shown in Figure S3. An increase in loading led to a decrease in the half-life of MRSA.
Figure 5. The effect of Ag2O loading on antimicrobial activity. The data used for Ag2O coating is the same as in Figure 4. The “Ag2O Coating” label is for the coating used elsewhere in this manuscript, and Ag2O-33% and Ag2O-66% indicate coating loadings that have 33% and 66% of that loading, respectively. Data as a function of loading is shown in Figure S3. An increase in loading led to a decrease in the half-life of MRSA.
Microorganisms 12 00083 g005
Figure 6. The antimicrobial activity of the Ag2O coating is retained after abrasion. The results show a 4-log killing of MRSA on the coating in 60 min.
Figure 6. The antimicrobial activity of the Ag2O coating is retained after abrasion. The results show a 4-log killing of MRSA on the coating in 60 min.
Microorganisms 12 00083 g006
Table 1. Statistics summarizing the antimicrobial activity of the Ag2O coating.
Table 1. Statistics summarizing the antimicrobial activity of the Ag2O coating.
OrganismKilling, 60 minReduction, 60 minHalf-Life (min.) 1
MRSA cells>99.9%>99.9%3.3–3.8
P. aeruginosa cells>99.9%>99.9%2.6–3.3
C. difficile spores98.55%98.55%8.8–11.8
1 range indicates a 95% confidence interval. Statistics are for three independent experiments. Equations for killing, reduction, and half-life are in Supplementary Information.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hosseini, M.; Huang, J.; Williams, M.D.; Gonzalez, G.A.; Jiang, X.; Falkinham, J.O., III; Ducker, W.A. Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Clostridioides difficile Spores, MRSA, and Pseudomonas aeruginosa. Microorganisms 2024, 12, 83. https://doi.org/10.3390/microorganisms12010083

AMA Style

Hosseini M, Huang J, Williams MD, Gonzalez GA, Jiang X, Falkinham JO III, Ducker WA. Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Clostridioides difficile Spores, MRSA, and Pseudomonas aeruginosa. Microorganisms. 2024; 12(1):83. https://doi.org/10.3390/microorganisms12010083

Chicago/Turabian Style

Hosseini, Mohsen, Jinge Huang, Myra D. Williams, Gerardo Alexander Gonzalez, Xiuping Jiang, Joseph O. Falkinham, III, and William A. Ducker. 2024. "Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Clostridioides difficile Spores, MRSA, and Pseudomonas aeruginosa" Microorganisms 12, no. 1: 83. https://doi.org/10.3390/microorganisms12010083

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop